![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/26/2904429/30925/en/Agile-Therapeutics-Inc-Announces-Definitive-Merger-Agreement-with-Insud-Pharma-S-L.html
https://www.globenewswire.com/news-release/2024/05/15/2882898/30925/en/Agile-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/28/2853966/30925/en/Agile-Therapeutics-Reports-Fourth-Quarter-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/25/2852010/30925/en/Agile-Therapeutics-Announces-Delisting-from-Nasdaq.html
https://www.globenewswire.com/news-release/2024/03/21/2850066/30925/en/Correction-Agile-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provide-Business-Update-on-Thursday-March-28-2024.html
https://www.globenewswire.com/news-release/2024/03/20/2849348/30925/en/Agile-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provide-Business-Update-on-Friday-March-22-2024.html
https://www.globenewswire.com//news-release/2024/03/13/2845329/30925/en/Agile-Therapeutics-Completes-Pay-off-of-Debt-and-Remains-Focused-on-Business-Plan-Execution.html
https://www.globenewswire.com//news-release/2024/02/22/2833759/30925/en/Agile-Therapeutics-Announces-Exercise-of-Warrants-for-4-8-Million-Gross-Proceeds.html
https://www.globenewswire.com//news-release/2024/02/15/2830416/30925/en/Agile-Therapeutics-Announces-Extension-Granted-by-Nasdaq-Hearings-Panel-to-Regain-Compliance-with-the-Stockholders-Equity-Continued-Listing-Requirement-Provides-Performance-Update.html
https://www.globenewswire.com//news-release/2024/01/23/2814231/30925/en/The-Biden-Harris-Administration-Announces-New-Guidance-to-Enable-Expanded-Access-to-All-FDA-Approved-Contraceptives-Without-Cost.html